Treatment of vulval Crohn's disease with infliximab

Authors: Preston, P. W.; Hudson, N.1; Lewis, F. M.

Source: Clinical & Experimental Dermatology, Volume 31, Number 3, May 2006 , pp. 378-380(3)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Summary

Anti-tumour necrosis factor-α therapy of Crohn's disease (CD) with infliximab has proved a major advance in the treatment of patients with difficult disease. We report our experience of the use of infliximab in a patient with recalcitrant vulval CD. The introduction of infliximab has improved disease control, although a search for an optimum remittive dosing schedule is ongoing.

Document Type: Research article

DOI: 10.1111/j.1365-2230.2006.02079.x

Affiliations: 1: Gastroenterology, Worcestershire Royal Hospital, Worcester, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A